Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (10847)	3/4/2004 10:25:31 PM
From: keokalani'nui	Respond to of 52153

First time I have ever used the ignore feature on SI in four years of membership. Goodbye Senior Jiminez. If he was interested in DATA he'd notice that the range of posts is more like ALL WAKING (not working) HOURS.

To: IRWIN JAMES FRANKEL who wrote (10847)	3/5/2004 3:03:21 AM
From: zeta1961	Respond to of 52153

Antegren... IJ, I concur with your statements about the beta interferons and anti-body response...a problem for all diseases in which interferons are used...another point...the side effect prorile of the B-interferons...flu-like symptoms, fatigue and depression(both being coexisting problems with MS patients) From what I hear, the patients on study like the regimine...some claim they can tell they are on the Antegren and not placebo just based on how they are feeling and decreasing relapses...also, monthly IV clinic infusions which one patient is quite positive both for convenience and very importantly, the reimbursment...much more likely to get reimbursed since it's considered a medical procedure......headache relieved by Tylenol the primary side effect... Not to mention it's fascinating method of action... Zeta...